Tags
approved Covid-19 vaccines, BioNTech vaccine, CICP, Comirnaty, Countermeasures Injury Compensation Program, Covid-19 vaccines, Emergency Use Authorization, EUA, expired Covid-19 vaccine stock, National Vaccine Injury Compensation Program, Pfizer, Pfizer BioNTech Covid-19 vaccine, Pfizer BioNTech vaccine expiration dates, Pfizer BioNTech vaccine expiration extension, Pfizer vaccine, US FDA, vaccine liability, vaccine mandates, VICP
In case you missed it, they’ve been giving people in the US and Canada expired vaccines since last summer. Both Canada and the US appear to have had batches of Pfizer-BioNTech which expired in February and they had extended use by three months: “vials of Pfizer-BioNTech COVID-19 Vaccine with an expiry date of August 2021 through February 2022 printed on the label may remain in use for 3 months beyond the printed date as long as all approved storage conditions have been maintained”. https://archive.vn/MnNTM -https://miningawareness.wordpress.com/2022/01/13/pfizer-biontech-covid-19-vax-batches-expire-soon-pfizer-promises-new-vax-who-calls-for-new-vax-new-vax-from-notorious-baric-lab/
Based on the new table, they appear to have continued to produce the unapproved Pfizer-BioNTech version, under the Emergency Use Authorization, EUA, even after fully approving Comirnaty (European version of BioNTech vaccine)!
Are they having trouble getting shot of this product or did they continue to produce the not fully approved Emergency Use product?
Click to access Expiry_Doc.pdf
“Pfizer Statement: “Pfizer received inital FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufactured. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced” https://www.cdc.gov/vaccines/programs/iis/COVID-19-related-codes.html
Despite the unclear wording, as of 17 May, the Pfizer-BioNTech vaccine is apparently still under EUA, rather than fully approved, helping to protect Pfizer against legal action and allowing them to get rid of their old stock: “Pfizer-BioNTech COVID-19 Vaccine is FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 5 years of age and older.” https://web.archive.org/web/20220601025206/https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-us-emergency-use-authorization
Instead of approving the Pfizer-BioNTech vaccine, the US FDA approved-licensed the European BioNTech mRNA vaccine named “Comirnaty”, which is “legally distinct with certain differences” from Pfizer vaccine. Emergency Use Authorization apparently helps protect Pfizer from liability. However, from our understanding, vaccine mandates for military, etc., cannot be undertaken for non-licensed vaccines. Comirnaty, as approved, is not available in the United States, and apparently never will be. Whether they will produce Pfizer-BioNTech after they get rid of the old EUA stock, remains to be seen. https://miningawareness.wordpress.com/2021/08/25/fda-only-renewed-emergency-use-authorization-for-pfizer-approval-was-for-biontechs-comirnaty-with-years-of-additional-safety-studies-required-thru-2027/
“Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age” Tuesday, May 17, 2022 – 11:40am https://web.archive.org/web/20220601025206/https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-us-emergency-use-authorization
Currently the Covid-19 vaccines apparently remain under the EUA and, hence, under CICP. Once approved if recommended for routine administration it could fall under VICP:
“Comparison of Countermeasures Injury Compensation Program (CICP) to the National Vaccine Injury Compensation Program (VICP)” https://www.hrsa.gov/cicp/cicp-vicp
“The National Vaccine Injury Compensation Program (VICP) covers most vaccines routinely given in the U.S. For a vaccine to be covered, the Centers for Disease Control and Prevention (CDC) must recommend the category of vaccine for routine administration to children or pregnant women, and it must be subject to an excise tax by federal law.” https://www.hrsa.gov/vaccine-compensation/covered-vaccines/index.html
Currently, the Covid-19 vaccines are not on the list. However, if they get approved and are recommended, then liability will be limited: “The National Vaccine Injury Compensation Program (VICP) is an alternative to the tort system for resolving vaccine injury petitions. Whether a vaccine manufacturer or administrator is afforded the liability protections of the National Childhood Vaccine Injury Act of 1986, as amended, (the Act) depends upon whether the vaccine is covered under the VICP. Under the Act, persons with petitions of vaccine-related injuries or deaths resulting from covered vaccines must first exhaust their remedies under the VICP before they can pursue legal actions against vaccine manufacturers or administrators. To exhaust the remedies available under the VICP and pursue a legal action against a vaccine manufacturer or administrator outside of the VICP, a VICP petitioner must either withdraw his or her petition (if the special master of the U. S. Court of Federal Claims (Court) has failed to issue a decision or the Court has failed to enter judgment within the time provided by the Act) or reject the judgment under the VICP.
Although the Act provides liability protections to vaccine manufacturers and vaccine administrators who administer covered vaccines in many circumstances, these protections are not absolute. There are instances when a vaccine manufacturer or administrator who gives a covered vaccine is not protected from liability by the Act, such as when an individual files a petition and is requesting damages of $1,000 or less. In this case, a civil suit against a vaccine manufacturer or an administrator may be permitted to be filed in state or federal court without first filing a petition in the VICP. In addition, if the VICP has paid a petitioner for a vaccine-related injury, the VICP may be able to pursue its own action against a vaccine manufacturer or administrator using its subrogation rights.” https://www.hrsa.gov/vaccine-compensation/faq
The original has more information but it wasn’t possible to get a complete screen shot: https://www.cdc.gov/vaccines/programs/iis/COVID-19-related-codes.html
hhttps://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine
If you need legal advice, you may want to contact this lawyer (Younts) for a reference:
Successful Argument Before Navy Board That Experimental Covid-19 Vaccine Order Was Not Lawful
Hat Tip – This person wisely did their own field research at their local pharmacy, and is kindly sharing the information: “THE FOOLING OF AMERICA CONTINUES: An Update on Availability of “Approved” COVID-19 Vaccines in the U.S.” By E.M. McCrum, May 30, 2022: https://emmccrum.substack.com/p/the-fooling-of-america-continues
Mining Awareness + 
You must be logged in to post a comment.